In the News with GMI
In the News
How Clinical Trials Are Advancing Treatments for ADHD
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of children and adults worldwide, influencing focus, behavior, and daily functioning. While traditional medications and behavioral therapies have helped many
What’s Next for Alzheimer’s and Dementia Research in 2026?
Alzheimer’s and dementia continue to be some of the most pressing health challenges worldwide. As research advances, 2026 is shaping up to be a year
Alzheimer’s Disease: How Clinical Trials Are Helping Patients Maintain Cognitive Function
Alzheimer’s disease is a progressive neurological disorder that impacts memory, thinking, and behavior, often making daily life increasingly difficult. While there is currently no cure,
New Approaches to Treating ADHD Through Clinical Research
Attention Deficit Hyperactivity Disorder (ADHD) affects millions worldwide, impacting focus, impulse control, and daily functioning. While traditional treatments have helped many, ongoing clinical research is
The Importance of Data Integrity in Alzheimer’s and Dementia Clinical Research
In clinical research, especially in areas as critical as Alzheimer’s and dementia, the accuracy and reliability of data are essential. Ensuring data integrity not only
Why Participating in Clinical Trials Is Critical for Advancing ADHD Research
Clinical trials are at the heart of medical progress, helping researchers better understand conditions like Attention-Deficit/Hyperactivity Disorder (ADHD). These studies rely on volunteers to evaluate
